Fetal alcohol spectrum disorder: Potential role of endocannabinoids signaling

Brain Sciences

Volumn 5, Issue 4, 2015, Pages 456-493

  Basavarajappa, Balapal S ^a,b,c  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Brain development; CB1 receptors; Fetal alcohol; Intellectual disability; Learning and memory; Synaptic plasticity

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID RECEPTOR; CASPASE 3; ENDOCANNABINOID; FATTY ACID BINDING PROTEIN; FOCAL ADHESION KINASE; LIPOPROTEIN LIPASE; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN P130; PROTEIN TYROSINE KINASE; RIMONABANT;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COGNITION; EXECUTIVE FUNCTION; FETAL ALCOHOL SYNDROME; HUMAN; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; PREGNANCY; PRENATAL DRUG EXPOSURE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TASK PERFORMANCE;

EID: 84985952914     PISSN: None     EISSN: 20763425     Source Type: Journal    
DOI: 10.3390/brainsci5040456     Document Type: Review

References (311)

1. Jones, K.L.; Smith, D.W.; Ulleland, C.N.; Streissguth, P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1973, 1, 1267-1271.
2. Jones, K.L.; Smith, D.W. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973, 2, 999-1001.
3. Alati, R.; al Mamun, A.; Williams, G.M.; O’Callaghan, M.; Najman, J.M.; Bor, W. In utero alcohol exposure and prediction of alcohol disorders in early adulthood: A birth cohort study. Arch. Gen. Psychiatry 2006, 63, 1009-1016.
4. Autti-Ramo, I.; Fagerlund, A.; Ervalahti, N.; Loimu, L.; Korkman, M.; Hoyme, H.E. Fetal alcohol spectrum disorders in Finland: Clinical delineation of 77 older children and adolescents. Am. J. Med. Genet. Part A 2006, 140, 137-143.
5. Ceccanti, M.; Alessandra Spagnolo, P.; Tarani, L.; Luisa Attilia, M.; Chessa, L.; Mancinelli, R.; Stegagno, M.; Francesco Sasso, G.; Romeo, M.; Jones, K.L.; et al. Clinical delineation of fetal alcohol spectrum disorders (FASD) in Italian children: Comparison and contrast with other racial/ethnic groups and implications for diagnosis and prevention. Neurosci. Biobehav. Rev. 2007, 31, 270-277.
6. Spohr, H.L.; Willms, J.; Steinhausen, H.C. Fetal alcohol spectrum disorders in young adulthood. J. Pediatr. 2007, 150, 175-179.
7. Streissguth, A.P.; Aase, J.M.; Clarren, S.K.; Randels, S.P.; LaDue, R.A.; Smith, D.F. Fetal alcohol syndrome in adolescents and adults. JAMA 1991, 265, 1961-1967.
8. Sokol, R.J.; Delaney-Black, V.; Nordstrom, B. Fetal alcohol spectrum disorder. JAMA 2003, 290, 2996-2999.
9. Burd, L.; Klug, M.G.; Martsolf, J.T.; Kerbeshian, J. Fetal alcohol syndrome: Neuropsychiatric phenomics. Neurotoxicol. Teratol. 2003, 25, 697-705.
10. Mattson, S.N.; Crocker, N.; Nguyen, T.T. Fetal alcohol spectrum disorders: Neuropsychological and behavioral features. Neuropsychol. Rev. 2011, 21, 81-101.
11. Mattson, S.N.; Riley, E.P. A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol. Clin. Exp. Res. 1998, 22, 279-294.
12. Mattson, S.N.; Riley, E.P.; Gramling, L.; Delis, D.C.; Jones, K.L. Neuropsychological comparison of alcohol-exposed children with or without physical features of fetal alcohol syndrome. Neuropsychology 1998, 12, 146-153.
13. Goodman, A.M.; Delis, D.C.; Mattson, S.N. Normative data for 4-year-old children on the California Verbal Learning Test-Children's Version. Clin. Neuropsychol. 1999, 13, 274-282.
14. Mattson, S.N.; Goodman, A.M.; Caine, C.; Delis, D.C.; Riley, E.P. Executive functioning in children with heavy prenatal alcohol exposure. Alcohol. Clin. Exp. Res. 1999, 23, 1808-1815.
15. Sood, B.; Delaney-Black, V.; Covington, C.; Nordstrom-Klee, B.; Ager, J.; Templin, T.; Janisse, J.; Martier, S.; Sokol, R.J. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose-response effect. Pediatrics 2001, 108, E34.
16. Streissguth, A.P.; Bookstein, F.L.; Sampson, P.D.; Barr, H.M. Neurobehavioral effects of prenatal alcohol: Part III. PLS analyses of neuropsychologic tests. Neurotoxicol. Teratol. 1989, 11, 493-507.
17. Bailey, B.N.; Delaney-Black, V.; Covington, C.Y.; Ager, J.; Janisse, J.; Hannigan, J.H.; Sokol, R.J. Prenatal exposure to binge drinking and cognitive and behavioral outcomes at age 7 years. Am. J. Obstet. Gynecol. 2004, 191, 1037-1043.
18. Bonthius, D.J.; Goodlett, C.R.; West, J.R. Blood alcohol concentration and severity of microencephaly in neonatal rats depend on the pattern of alcohol administration. Alcohol 1988, 5, 209-214.
19. Guerri, C.; Bazinet, A.; Riley, E.P. Foetal Alcohol Spectrum Disorders and alterations in brain and behaviour. Alcohol Alcohol. 2009, 44, 108-114.
20. May, P.A.; Gossage, J.P.; Kalberg, W.O.; Robinson, L.K.; Buckley, D.; Manning, M.; Hoyme, H.E. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev. Disabil. Res. Rev. 2009, 15, 176-192.
21. Bertrand, J.; Floyd, R.L.; Weber, M.K.; O’Connor, M.; Riley, E.P.; Johnson, K.A.; Cohen, D.E. Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2004.
22. Dalen, K.; Bruaroy, S.; Wentzel-Larsen, T.; Laegreid, L.M. Cognitive functioning in children prenatally exposed to alcohol and psychotropic drugs. Neuropediatrics 2009, 40, 162-167.
23. Mattson, S.N.; Riley, E.P.; Gramling, L.; Delis, D.C.; Jones, K.L. Heavy prenatal alcohol exposure with or without physical features of fetal alcohol syndrome leads to IQ deficits. J. Pediatr. 1997, 131, 718-721.
24. Alati, R.; Clavarino, A.; Najman, J.M.; O’Callaghan, M.; Bor, W.; Mamun, A.A.; Williams, G.M. The developmental origin of adolescent alcohol use: Findings from the Mater University Study of Pregnancy and its outcomes. Drug Alcohol Depend. 2008, 98, 136-143.
25. Fried, P.A.; Watkinson, B. 12-and 24-month neurobehavioural follow-up of children prenatally exposed to marihuana, cigarettes and alcohol. Neurotoxicol. Teratol. 1988, 10, 305-313.
26. Streissguth, A.P.; Barr, H.M.; Sampson, P.D. Moderate prenatal alcohol exposure: Effects on child IQ and learning problems at age 7 1/2 years. Alcohol. Clin. Exp. Res. 1990, 14, 662-669.
27. Willford, J.A.; Leech, S.L.; Day, N.L. Moderate prenatal alcohol exposure and cognitive status of children at age 10. Alcoholism 2006, 30, 1051-1059.
28. Chasnoff, I.J.; Wells, A.M.; Telford, E.; Schmidt, C.; Messer, G. Neurodevelopmental functioning in children with FAS, pFAS, and ARND. J. Dev. Behav. Pediatr. 2010, 31, 192-201.
29. Aragon, A.S.; Kalberg, W.O.; Buckley, D.; Barela-Scott, L.M.; Tabachnick, B.G.; May, P.A. Neuropsychological study of FASD in a sample of American Indian children: Processing simple versus complex information. Alcohol. Clin. Exp. Res. 2008, 32, 2136-2148.
30. Green, C.R.; Mihic, A.M.; Nikkel, S.M.; Stade, B.C.; Rasmussen, C.; Munoz, D.P.; Reynolds, J.N. Executive function deficits in children with fetal alcohol spectrum disorders (FASD) measured using the Cambridge Neuropsychological Tests Automated Battery (CANTAB). J. Child Psychol. Psychiatry 2009, 50, 688-697.
31. Kodituwakku, P.W.; Adnams, C.M.; Hay, A.; Kitching, A.E.; Burger, E.; Kalberg, W.O.; Viljoen, D.L.; May, P.A. Letter and category fluency in children with fetal alcohol syndrome from a community in South Africa. J. Stud. Alcohol. 2006, 67, 502-509.
32. Kodituwakku, P.W.; Handmaker, N.S.; Cutler, S.K.; Weathersby, E.K.; Handmaker, S.D. Specific impairments in self-regulation in children exposed to alcohol prenatally. Alcohol. Clin. Exp. Res. 1995, 19, 1558-1564.
33. Schonfeld, A.M.; Mattson, S.N.; Lang, A.R.; Delis, D.C.; Riley, E.P. Verbal and nonverbal fluency in children with heavy prenatal alcohol exposure. J. Stud. Alcohol. 2001, 62, 239-246.
34. Vaurio, L.; Riley, E.P.; Mattson, S.N. Differences in executive functioning in children with heavy prenatal alcohol exposure or attention-deficit/hyperactivity disorder. J. Int. Neuropsychol. Soc. 2008, 14, 119-129.
35. Mattson, S.N.; Riley, E.P.; Delis, D.C.; Stern, C.; Jones, K.L. Verbal learning and memory in children with fetal alcohol syndrome. Alcohol. Clin. Exp. Res. 1996, 20, 810-816.
36. Mattson, S.N.; Roebuck, T.M. Acquisition and retention of verbal and nonverbal information in children with heavy prenatal alcohol exposure. Alcohol. Clin. Exp. Res. 2002, 26, 875-882.
37. Roebuck-Spencer, T.M.; Mattson, S.N. Implicit strategy affects learning in children with heavy prenatal alcohol exposure. Alcohol. Clin. Exp. Res. 2004, 28, 1424-1431.
38. Willford, J.A.; Richardson, G.A.; Leech, S.L.; Day, N.L. Verbal and visuospatial learning and memory function in children with moderate prenatal alcohol exposure. Alcohol. Clin. Exp. Res. 2004, 28, 497-507.
39. Kaemingk, K.L.; Mulvaney, S.; Halverson, P.T. Learning following prenatal alcohol exposure: Performance on verbal and visual multitrial tasks. Arch. Clin. Neuropsychol. 2003, 18, 33-47.
40. Willoughby, K.A.; Sheard, E.D.; Nash, K.; Rovet, J. Effects of prenatal alcohol exposure on hippocampal volume, verbal learning, and verbal and spatial recall in late childhood. J. Int. Neuropsychol. Soc. 2008, 14, 1022-1033.
41. Hamilton, D.A.; Kodituwakku, P.; Sutherland, R.J.; Savage, D.D. Children with Fetal Alcohol Syndrome are impaired at place learning but not cued-navigation in a virtual Morris water task. Behav. Brain Res. 2003, 143, 85-94.
42. Kaemingk, K.L.; Halverson, P.T. Spatial memory following prenatal alcohol exposure: More than a material specific memory deficit. Child Neuropsychol. 2000, 6, 115-128.
43. Rasmussen, C.; Horne, K.; Witol, A. Neurobehavioral functioning in children with fetal alcohol spectrum disorder. Child Neuropsychol. 2006, 12, 453-468.
44. Uecker, A.; Nadel, L. Spatial but not object memory impairments in children with fetal alcohol syndrome. Am. J. Ment. Retard. 1998, 103, 12-18.
45. Aronson, M.; Hagberg, B. Neuropsychological disorders in children exposed to alcohol during pregnancy: A follow-up study of 24 children to alcoholic mothers in Goteborg, Sweden. Alcohol. Clin. Exp. Res. 1998, 22, 321-324.
46. Chiodo, L.M.; Janisse, J.; Delaney-Black, V.; Sokol, R.J.; Hannigan, J.H. A metric of maternal prenatal risk drinking predicts neurobehavioral outcomes in preschool children. Alcohol. Clin. Exp. Res. 2009, 33, 634-644.
47. Conry, J. Neuropsychological deficits in fetal alcohol syndrome and fetal alcohol effects. Alcohol. Clin. Exp. Res. 1990, 14, 650-655.
48. Janzen, L.A.; Nanson, J.L.; Block, G.W. Neuropsychological evaluation of preschoolers with fetal alcohol syndrome. Neurotoxicol. Teratol. 1995, 17, 273-279.
49. Simmons, R.W.; Thomas, J.D.; Levy, S.S.; Riley, E.P. Motor response programming and movement time in children with heavy prenatal alcohol exposure. Alcohol 2010, 44, 371-378.
50. Simmons, R.W.; Wass, T.; Thomas, J.D.; Riley, E.P. Fractionated simple and choice reaction time in children with prenatal exposure to alcohol. Alcohol. Clin. Exp. Res. 2002, 26, 1412-1419.
51. Wass, T.S.; Simmons, R.W.; Thomas, J.D.; Riley, E.P. Timing accuracy and variability in children with prenatal exposure to alcohol. Alcohol. Clin. Exp. Res. 2002, 26, 1887-1896.
52. Mattson, S.N.; Roesch, S.C.; Fagerlund, A.; Autti-Ramo, I.; Jones, K.L.; May, P.A.; Adnams, C.M.; Konovalova, V.; Riley, E.P.; Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD). Toward a neurobehavioral profile of fetal alcohol spectrum disorders. Alcohol. Clin. Exp. Res. 2010, 34, 1640-1650.
53. Aragon, A.S.; Coriale, G.; Fiorentino, D.; Kalberg, W.O.; Buckley, D.; Gossage, J.P.; Ceccanti, M.; Mitchell, E.R.; May, P.A. Neuropsychological characteristics of Italian children with fetal alcohol spectrum disorders. Alcohol. Clin. Exp. Res. 2008, 32, 1909-1919.
54. Brown, R.T.; Coles, C.D.; Smith, I.E.; Platzman, K.A.; Silverstein, J.; Erickson, S.; Falek, A. Effects of prenatal alcohol exposure at school age. II. Attention and behavior. Neurotoxicol. Teratol. 1991, 13, 369-376.
55. Burden, M.J.; Jacobson, S.W.; Sokol, R.J.; Jacobson, J.L. Effects of prenatal alcohol exposure on attention and working memory at 7.5 years of age. Alcohol. Clin. Exp. Res. 2005, 29, 443-452.
56. Burden, M.J.; Mitchell, D.B. Implicit memory development in school-aged children with attention deficit hyperactivity disorder (ADHD): Conceptual priming deficit? Dev. Neuropsychol. 2005, 28, 779-807.
57. Jacobson, S.W.; Jacobson, J.L.; Sokol, R.J. Effects of fetal alcohol exposure on infant reaction time. Alcohol. Clin. Exp. Res. 1994, 18, 1125-1132.
58. Jacobson, S.W.; Jacobson, J.L.; Sokol, R.J.; Martier, S.S.; Ager, J.W. Prenatal alcohol exposure and infant information processing ability. Child Dev. 1993, 64, 1706-1721.
59. Nash, K.; Rovet, J.; Greenbaum, R.; Fantus, E.; Nulman, I.; Koren, G. Identifying the behavioural phenotype in Fetal Alcohol Spectrum Disorder: Sensitivity, specificity and screening potential. Arch. N.A. Ment. Health 2006, 9, 181-186.
60. Streissguth, A.P.; Sampson, P.D.; Olson, H.C.; Bookstein, F.L.; Barr, H.M.; Scott, M.; Feldman, J.; Mirsky, A.F. Maternal drinking during pregnancy: Attention and short-term memory in 14-year-old offspring-A longitudinal prospective study. Alcohol. Clin. Exp. Res. 1994, 18, 202-218.
61. Howell, K.K.; Lynch, M.E.; Platzman, K.A.; Smith, G.H.; Coles, C.D. Prenatal alcohol exposure and ability, academic achievement, and school functioning in adolescence: A longitudinal follow-up. J. Pediatr. Psychol. 2006, 31, 116-126.
62. Coles, C.D.; Platzman, K.A.; Lynch, M.E.; Freides, D. Auditory and visual sustained attention in adolescents prenatally exposed to alcohol. Alcohol. Clin. Exp. Res. 2002, 26, 263-271.
63. Mattson, S.N.; Calarco, K.E.; Lang, A.R. Focused and shifting attention in children with heavy prenatal alcohol exposure. Neuropsychology 2006, 20, 361-369.
64. Fryer, S.L.; McGee, C.L.; Matt, G.E.; Riley, E.P.; Mattson, S.N. Evaluation of psychopathological conditions in children with heavy prenatal alcohol exposure. Pediatrics 2007, 119, e733-e741.
65. Cummings, J.L. Frontal-subcortical circuits and human behavior. Arch. Neurol. 1993, 50, 873-880.
66. Fryer, S.L.; Tapert, S.F.; Mattson, S.N.; Paulus, M.P.; Spadoni, A.D.; Riley, E.P. Prenatal alcohol exposure affects frontal-striatal BOLD response during inhibitory control. Alcohol. Clin. Exp. Res. 2007, 31, 1415-1424.
67. Mattson, S.N.; Riley, E.P.; Sowell, E.R.; Jernigan, T.L.; Sobel, D.F.; Jones, K.L. A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. Alcohol. Clin. Exp. Res. 1996, 20, 1088-1093.
68. McGee, C.L.; Fryer, S.L.; Bjorkquist, O.A.; Mattson, S.N.; Riley, E.P. Deficits in social problem solving in adolescents with prenatal exposure to alcohol. Am. J. Drug Alcohol. Abuse 2008, 34, 423-431.
69. Schonfeld, A.M.; Mattson, S.N.; Riley, E.P. Moral maturity and delinquency after prenatal alcohol exposure. J. Stud. Alcohol. 2005, 66, 545-554.
70. Timler, G.R.; Olswang, L.B. Variable structure/variable performance: Parent and teacher perspectives on a school-age child with FAS. J. Posit. Behav. Interv. 2001, 3, 48-56.
71. Timler, G.R.; Olswang, L.B.; Coggins, T.E. "Do I know what I need to do?" A social communication intervention for children with complex clinical profiles. Lang. Speech Hear. Serv. Sch. 2005, 36, 73-85.
72. Newmann, F.; Wehlage, G.; Lamborn, S. The significance and sources of student engagement. In Student Engagement and Achievement in American Secondary Schools; Newman, F., Ed.; Teachers College Press: New York, NY, USA, 1992; pp. 11-39.
73. Floyd, R.L.; Weber, M.K.; Denny, C.; O’Connor, M.J. Prevention of fetal alcohol spectrum disorders. Dev. Disabil. Res. Rev. 2009, 15, 193-199.
74. O’Connor, M.J.; Paley, B. Psychiatric conditions associated with prenatal alcohol exposure. Dev. Disabil. Res. Rev. 2009, 15, 225-234.
75. Paley, B.; O’Connor, M.J. Intervention for individuals with fetal alcohol spectrum disorders: Treatment approaches and case management. Dev. Disabil. Res. Rev. 2009, 15, 258-267.
76. Abdollah, S.; Catlin, M.C.; Brien, J.F. Ethanol neuro-behavioural teratogenesis in the guinea pig: Behavioural dysfunction and hippocampal morphologic change. Can. J. Physiol. Pharmacol. 1993, 71, 776-782.
77. Butters, N.S.; Gibson, M.A.; Reynolds, J.N.; Brien, J.F. Effects of chronic prenatal ethanol exposure on hippocampal glutamate release in the postnatal guinea pig. Alcohol 2000, 21, 1-9.
78. Christie, B.R.; Swann, S.E.; Fox, C.J.; Froc, D.; Lieblich, S.E.; Redila, V.; Webber, A. Voluntary exercise rescues deficits in spatial memory and long-term potentiation in prenatal ethanol-exposed male rats. Eur. J. Neurosci. 2005, 21, 1719-1726.
79. Driscoll, C.D.; Streissguth, A.P.; Riley, E.P. Prenatal alcohol exposure: Comparability of effects in humans and animal models. Neurotoxicol. Teratol. 1990, 12, 231-237.
80. Iqbal, U.; Rikhy, S.; Dringenberg, H.C.; Brien, J.F.; Reynolds, J.N. Spatial learning deficits induced by chronic prenatal ethanol exposure can be overcome by non-spatial pre-training. Neurotoxicol. Teratol. 2006, 28, 333-341.
81. Johnson, T.B.; Goodlett, C.R. Selective and enduring deficits in spatial learning after limited neonatal binge alcohol exposure in male rats. Alcohol. Clin. Exp. Res. 2002, 26, 83-93.
82. Reyes, E.; Wolfe, J.; Savage, D.D. The effects of prenatal alcohol exposure on radial arm maze performance in adult rats. Physiol. Behav. 1989, 46, 45-48.
83. Richardson, D.P.; Byrnes, M.L.; Brien, J.F.; Reynolds, J.N.; Dringenberg, H.C. Impaired acquisition in the water maze and hippocampal long-term potentiation after chronic prenatal ethanol exposure in the guinea-pig. Eur. J. Neurosci. 2002, 16, 1593-1598.
84. Savage, D.D.; Becher, M.; de la Torre, A.J.; Sutherland, R.J. Dose-dependent effects of prenatal ethanol exposure on synaptic plasticity and learning in mature offspring. Alcohol. Clin. Exp. Res. 2002, 26, 1752-1758.
85. Sutherland, R.J.; McDonald, R.J.; Savage, D.D. Prenatal exposure to moderate levels of ethanol can have long-lasting effects on hippocampal synaptic plasticity in adult offspring. Hippocampus 1997, 7, 232-238.
86. Tan, S.E.; Berman, R.F.; Abel, E.L.; Zajac, C.S. Prenatal alcohol exposure alters hippocampal slice electrophysiology. Alcohol 1990, 7, 507-511.
87. Cebral, E.; Lasserre, A.; Rettori, V.; de Gimeno, M.A. Impaired mouse fertilization by low chronic alcohol treatment. Alcohol Alcohol. 1997, 32, 563-572.
88. Cebral, E.; Lasserre, A.; Rettori, V.; de Gimeno, M.A. Alterations in preimplantation in vivo development after preconceptional chronic moderate alcohol consumption in female mice. Alcohol Alcohol. 2000, 35, 336-343.
89. Coll, T.A.; Tito, L.P.; Sobarzo, C.M.; Cebral, E. Embryo developmental disruption during organogenesis produced by CF-1 murine periconceptional alcohol consumption. Birth Defects Res. Part B Dev. Reprod. Toxicol. 2011, 92, 560-574.
90. Lipinski, R.J.; Hammond, P.; O’Leary-Moore, S.K.; Ament, J.J.; Pecevich, S.J.; Jiang, Y.; Budin, F.; Parnell, S.E.; Suttie, M.; Godin, E.A.; et al. Ethanol-induced face-brain dysmorphology patterns are correlative and exposure-stage dependent. PLOS ONE 2012, 7, e43067.
91. Sulik, K.K. Craniofacial defects from genetic and teratogen-induced deficiencies in presomite embryos. Birth Defects Orig. Artic. Ser. 1984, 20, 79-98.
92. Sulik, K.K.; Johnston, M.C. Sequence of developmental alterations following acute ethanol exposure in mice: Craniofacial features of the fetal alcohol syndrome. Am. J. Anat. 1983, 166, 257-269.
93. Sulik, K.K.; Johnston, M.C.; Webb, M.A. Fetal alcohol syndrome: Embryogenesis in a mouse model. Science 1981, 214, 936-938.
94. Cartwright, M.M.; Smith, S.M. Stage-dependent effects of ethanol on cranial neural crest cell development: Partial basis for the phenotypic variations observed in fetal alcohol syndrome. Alcohol. Clin. Exp. Res. 1995, 19, 1454-1462.
95. Guerri, C.; Pascual, M.; Renau-Piqueras, J. Glia and fetal alcohol syndrome. Neurotoxicology 2001, 22, 593-599.
96. Rubert, G.; Minana, R.; Pascual, M.; Guerri, C. Ethanol exposure during embryogenesis decreases the radial glial progenitorpool and affects the generation of neurons and astrocytes. J. Neurosci. Res. 2006, 84, 483-496.
97. Fred, B.L.; Sampson, P.D.; Connor, P.D.; Streissguth, A.P. Midline Corpus Callosum is a Neuroanatomical Focus of Fetal Alcohol Damage. New Anat. Rec. 2002, 269, 162-174.
98. Guerri, C. Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure. Alcohol. Clin. Exp. Res. 1998, 22, 304-312.
99. Mazer, C.; Muneyyirci, J.; Taheny, K.; Raio, N.; Borella, A.; Whitaker-Azmitia, P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: A possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 1997, 760, 68-73.
100. Thomas, J.D.; Goodlett, C.R.; West, J.R. Alcohol-induced Purkinje cell loss depends on developmental timing of alcohol exposure and correlates with motor performance. Brain Res. Dev. Brain Res. 1998, 105, 159-166.
101. Hamre, K.M.; West, J.R. The effects of the timing of ethanol exposure during the brain growth spurt on the number of cerebellar Purkinje and granule cell nuclear profiles. Alcohol. Clin. Exp. Res. 1993, 17, 610-622.
102. Bonthius, D.J.; West, J.R. Alcohol-induced neuronal loss in developing rats: Increased brain damage with binge exposure. Alcohol. Clin. Exp. Res. 1990, 14, 107-118.
103. Bonthius, D.J.; West, J.R. Permanent neuronal deficits in rats exposed to alcohol during the brain growth spurt. Teratology 1991, 44, 147-163.
104. Livy, D.J.; Miller, E.K.; Maier, S.E.; West, J.R. Fetal alcohol exposure and temporal vulnerability: Effects of binge-like alcohol exposure on the developing rat hippocampus. Neurotoxicol. Teratol. 2003, 25, 447-458.
105. Tran, T.D.; Kelly, S.J. Critical periods for ethanol-induced cell loss in the hippocampal formation. Neurotoxicol. Teratol. 2003, 25, 519-528.
106. Goodlett, C.R.; Peterson, S.D.; Lundahl, K.R.; Pearlman, A.D. Binge-like alcohol exposure of neonatal rats via intragastric intubation induces both Purkinje cell loss and cortical astrogliosis. Alcohol. Clin. Exp. Res. 1997, 21, 1010-1017.
107. Izumi, Y.; Kitabayashi, R.; Funatsu, M.; Izumi, M.; Yuede, C.; Hartman, R.E.; Wozniak, D.F.; Zorumski, C.F. A single day of ethanol exposure during development has persistent effects on bi-directional plasticity, N-methyl-D-aspartate receptor function and ethanol sensitivity. Neuroscience 2005, 136, 269-279.
108. Noel, M.; Norris, E.H.; Strickland, S. Tissue plasminogen activator is required for the development of fetal alcohol syndrome in mice. Proc. Natl. Acad. Sci. USA 2011, 108, 5069-5074.
109. Subbanna, S.; Basavarajappa, B.S. Pre-administration of G9a/GLP inhibitor during synaptogenesis prevents postnatal ethanol-induced LTP deficits and neurobehavioral abnormalities in adult mice. Exp. Neurol. 2014, 261, 34-43.
110. Subbanna, S.; Nagaraja, N.N.; Umapathy, N.S.; Pace, B.S.; Basavarajappa, B.S. Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice. Int. J. Neuropsychopharmacol. 2015, doi:10.1093/ijnp/pyu028.
111. Subbanna, S.; Shivakumar, M.; Psychoyos, D.; Xie, S.; Basavarajappa, B.S. Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic and memory deficits. J. Neuosci. 2013, 33, 6350-6366.
112. Wilson, D.A.; Peterson, J.; Basavaraj, B.S.; Saito, M. Local and regional network function in behaviorally relevant cortical circuits of adult mice following postnatal alcohol exposure. Alcohol. Clin. Exp. Res. 2011, 35, 1974-1984.
113. Miller, M.W. Effect of pre-or postnatal exposure to ethanol on the total number of neurons in the principal sensory nucleus of the trigeminal nerve: Cell proliferation and neuronal death. Alcohol. Clin. Exp. Res. 1995, 19, 1359-1363.
114. Noctor, S.C.; Flint, A.C.; Weissman, T.A.; Dammerman, R.S.; Kriegstein, A.R. Neurons derived from radial glial cells establish radial units in neocortex. Nature 2001, 409, 714-720.
115. Valles, S.; Pitarch, J.; Renau-Piqueras, J.; Guerri, C. Ethanol exposure affects glial fibrillary acidic protein gene expression and transcription during rat brain development. J. Neurochem. 1997, 69, 2484-2493.
116. Valles, S.; Sancho-Tello, M.; Minana, R.; Climent, E.; Renau-Piqueras, J.; Guerri, C. Glial fibrillary acidic protein expression in rat brain and in radial glia culture is delayed by prenatal ethanol exposure. J. Neurochem. 1996, 67, 2425-2433.
117. Cartwright, M.M.; Tessmer, L.L.; Smith, S.M. Ethanol-induced neural crest apoptosis is coincident with their endogenous death, but is mechanistically distinct. Alcohol. Clin. Exp. Res. 1998, 22, 142-149.
118. Liesi, P. Ethanol-exposed central neurons fail to migrate and undergo apoptosis. J. Neurosci. Res. 1997, 48, 439-448.
119. Camarillo, C.; Miranda, R.C. Ethanol exposure during neurogenesis induces persistent effects on neural maturation: Evidence from an ex vivo model of fetal cerebral cortical neuroepithelial progenitor maturation. Gene Exp. 2008, 14, 159-171.
120. Prock, T.L.; Miranda, R.C. Embryonic cerebral cortical progenitors are resistant to apoptosis, but increase expression of suicide receptor DISC-complex genes and suppress autophagy following ethanol exposure. Alcohol. Clin. Exp. Res. 2007, 31, 694-703.
121. Ikonomidou, C.; Bittigau, P.; Ishimaru, M.J.; Wozniak, D.F.; Koch, C.; Genz, K.; Price, M.T.; Stefovska, V.; Hörster, F.; Tenkova, T.; et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000, 287, 1056-1060.
122. Guerri, C.; Climent, E.; Pascual, M. Ethanol exposure emhances apoptosis during brain development and affects brain-derived neurotrophic factor and its TrkB receptors. Alcohol Alcohol. 2001, 36, 437.
123. Sadrian, B.; Subbanna, S.; Wilson, D.A.; Basavarajappa, B.S.; Saito, M. Lithium prevents long-term neural and behavioral pathology induced by early alcohol exposure. Neuroscience 2012, 206, 122-135.
124. Subbanna, S.; Shivakumar, M.; Umapathy, N.S.; Saito, M.; Mohan, P.S.; Kumar, A.; Nixon, R.A.; Verin, A.D.; Psychoyos, D.; Basavarajappa, B.S. G9a-mediated histone methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain. Neurobiol. Dis. 2013, 54, 475-485.
125. Goodlett, C.R.; Horn, K.H.; Zhou, F.C. Alcohol teratogenesis: Mechanisms of damage and strategies for intervention. Exp. Biol. Med. 2005, 230, 394-406.
126. Guerri, C. Mechanisms involved in central nervous system dysfunctions induced by prenatal ethanol exposure. Neurotox. Res. 2002, 4, 327-335.
127. Subbanna, S.; Psychoyos, D.; Shan, X.; Basavarajappa, B.S. Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neurodegeneration in neonatal mice. J. Neurochem. 2015, 134, 276-287.
128. Deltour, L.; Ang, H.L.; Duester, G. Ethanol inhibition of retinoic acid synthesis as a potential mechanism for fetal alcohol syndrome. FASEB J. 1996, 10, 1050-1057.
129. Liu, F.; Chen, X.; Allali-Hassani, A.; Quinn, A.M.; Wasney, G.A.; Dong, A.; Barsyte, D.; Kozieradzki, I.; Senisterra, G.; Chau, I.; et al. Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J. Med. Chem. 2009, 52, 7950-7953.
130. Nagre, N.N.; Subbanna, S.; Shivakumar, M.; Psychoyos, D.; Basavarajappa, B.S. CB1-receptor knockout neonatal mice are protected against ethanol-induced impairments of DNMT1, DNMT3A and DNA methylation. J. Neurochem. 2015, 132, 429-442.
131. Rifas, L.; Towler, D.A.; Avioli, L.V. Gestational exposure to ethanol suppresses msx2 expression in developing mouse embryos. Proc. Natl. Acad. Sci. USA 1997, 94, 7549-7554.
132. Subbanna, S.; Nagre, N.N.; Shivakumar, M.; Umapathy, N.S.; Psychoyos, D.; Basavarajappa, B.S. Ethanol induced acetylation of histone at G9a Exon1 and G9a-mediated histone H3 dimethylation leads to neurodegeneration in neonatal mice. Neuroscience 2014, 258C, 422-432.
133. Miranda, R.C. MicroRNAs and fetal brain development: Implications for ethanol teratology during the second trimester period of neurogenesis. Front. Genet. 2012, 3, 77.
134. Sathyan, P.; Golden, H.B.; Miranda, R.C. Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: Evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J. Neurosci. 2007, 27, 8546-8557.
135. Miller, M. Early exposure to ethanol affects the proliferation of neuronal precursors. In Brain Development Normal Processes and Effects of Alcohol and Nicotine; Miller, M., Ed.; Oxford University Press: Oxford, UK, 2006; pp. 182-198.
136. Mooney, S.M.; Miller, M.W.; Henderson, G.I. Intracellular events in ethanol-induced neuronal death. In Brain Development Normal Processes and Effects of Alcohol and Nicotine; Miller, M., Ed.; Oxford University Press: Oxford, UK, 2006; pp. 267-278.
137. Siegenthaler, J.A.; Miller, M.W. Mechanisms of ethanol-induced alterations in neuronal migration. In Brain Development Normal Processes and Effects of Alcohol and Nicotine; Miller, M.W., Ed.; Oxford University Press: Oxford, UK, 2006; pp. 216-229.
138. Cui, S.J.; Tewari, M.; Schneider, T.; Rubin, R. Ethanol promotes cell death by inhibition of the insulin-like growth factor I receptor. Alcohol. Clin. Exp. Res. 1997, 21, 1121-1127.
139. Minana, R.; Climent, E.; Barettino, D.; Segui, J.M.; Renau-Piqueras, J.; Guerri, C. Alcohol exposure alters the expression pattern of neural cell adhesion molecules during brain development. J. Neurochem. 2000, 75, 954-964.
140. Ramanathan, R.; Wilkemeyer, M.F.; Mittal, B.; Perides, G.; Charness, M.E. Alcohol inhibits cell-cell adhesion mediated by human L1. J. Cell Biol. 1996, 133, 381-390.
141. Wilkemeyer, M.F.; Menkari, C.E.; Charness, M.E. Novel antagonists of alcohol inhibition of l1-mediated cell adhesion: Multiple mechanisms of action. Mol. Pharmacol. 2002, 62, 1053-1060.
142. Wilkemeyer, M.F.; Sebastian, A.B.; Smith, S.A.; Charness, M.E. Antagonists of alcohol inhibition of cell adhesion. Proc. Natl. Acad. Sci. USA 2000, 97, 3690-3695.
143. Zhang, F.X.; Rubin, R.; Rooney, T.A. Ethanol induces apoptosis in cerebellar granule neurons by inhibiting insulin-like growth factor 1 signaling. J. Neurochem. 1998, 71, 196-204.
144. Guerri, C.; Montoliu, C.; Renau-Piqueras, J. Involvement of free radical mechanism in the toxic effects of alcohol: Implications for fetal alcohol syndrome. Adv. Exp. Med. Biol. 1994, 366, 291-305.
145. Olney, J.W.; Ishimaru, M.J.; Bittigau, P.; Ikonomidou, C. Ethanol-induced apoptotic neurodegeneration in the developing brain. Apoptosis 2000, 5, 515-521.
146. Olney, J.W.; Tenkova, T.; Dikranian, K.; Muglia, L.J.; Jermakowicz, W.J.; D'Sa, C.; Roth, K.A. Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol. Dis. 2002, 9, 205-219.
147. Olney, J.W.; Wozniak, D.F.; Farber, N.B.; Jevtovic-Todorovic, V.; Bittigau, P.; Ikonomidou, C. The enigma of fetal alcohol neurotoxicity. Ann. Med. 2002, 34, 109-119.
148. Olney, J.W.; Young, C.; Wozniak, D.F.; Jevtovic-Todorovic, V.; Ikonomidou, C. Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol. Sci. 2004, 25, 135-139.
149. Saito, M.; Chakraborty, G.; Hegde, M.; Ohsie, J.; Paik, S.M.; Vadasz, C. Involvement of ceramide in ethanol-induced apoptotic neurodegeneration in the neonatal mouse brain. J. Neurochem. 2010, 115, 168-177.
150. Young, C.; Roth, K.A.; Klocke, B.J.; West, T.; Holtzman, D.M.; Labruyere, J.; Qin, Y.Q.; Dikranian, K.; Olney, J.W. Role of caspase-3 in ethanol-induced developmental neurodegeneration. Neurobiol. Dis. 2005, 20, 608-614.
151. Guerri, C.; Rubert, G.; Pascual, M. Glial targets of developmental exposure to ethanol. In Brain Development; Miller, M.W., Ed.; Oxford University Press: Oxford, UK, 2006; pp. 295-312.
152. Mechoulam, R.; Parker, L.A. The endocannabinoid system and the brain. Annu. Rev. Psychol. 2013, 64, 21-47.
153. Kreitzer, A.C.; Regehr, W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001, 29, 717-727.
154. Ohno-Shosaku, T.; Maejima, T.; Kano, M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminal. Neuron 2001, 29, 729-738.
155. Wilson, R.I.; Nicoll, R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410, 588-592.
156. Alger, B.E. Retrograde signaling in the regulation of synaptic transmission: Focus on endocannabinoids. Prog. Neurobiol. 2002, 68, 247-286.
157. Basavarajappa, B.S.; Arancio, O. Synaptic plasticity: Emerging role for endocannabinoid system. In Synaptic Plasticity New Research; Kaiser, T.F., Peters, F.J., Eds.; Nova Science Publishers, Inc.: New York, NY, USA, 2008; pp. 77-112.
158. Di Marzo, V.; Fontana, A.; Cadas, H.; Schinelli, S.; Cimino, G.; Schwartz, J.C.; Piomelli, D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372, 686-691.
159. Cadas, H.; di Tomaso, E.; Piomelli, D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 1997, 17, 1226-1242.
160. Mechoulam, R.; Fride, E.; di Marzo, V. Endocannabinoids. Eur. J. Pharmacol. 1998, 359, 1-18.
161. Basavarajappa, B.S.; Hungund, B.L. Chronic ethanol increases the cannabinoid receptor agonist, anandamide and its precursor N-arachidonyl phosphatidyl ethanolamine in SK-N-SH Cells. J. Neurochem. 1999, 72, 522-528.
162. Basavarajappa, B.S.; Saito, M.; Cooper, T.B.; Hungund, B.L. Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochem. Biophys. Acta 2000, 1535, 78-86.
163. Basavarajappa, B.S.; Saito, M.; Cooper, T.B.; Hungund, B.L. Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur. J. Pharmacol. 2003, 466, 73-83.
164. Giuffrida, A.; Parsons, L.H.; Kerr, T.M.; Rodriguez de Fonseca, F.; Navarro, M.; Piomelli, D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 1999, 2, 358-363.
165. Devane, W.A.; Hanus, L.; Breuer, A.; Pertwee, R.G.; Stevenson, L.A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946-1949.
166. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N.E.; Schatz, A.R.; Gopher, A.; Almog, S.; Martin, B.R.; Compton, D.R.; et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50, 83-90.
167. Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215, 89-97.
168. Hanus, L.; Abu-Lafi, S.; Fride, E.; Breuer, A.; Vogel, Z.; Shalev, D.E.; Kustanovich, I, Mechoulam, R. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. 2001, 98, 3662-3665.
169. Porter, A.C.; Sauer, J.M.; Knierman, M.D.; Becker, G.W.; Berna, M.J.; Bao, J.; Nomikos, G.G.; Carter, P.; Bymaster, F.P.; Leese, A.B.; et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther. 2002, 301, 1020-1024.
170. Huang, S.M.; Bisogno, T.; Trevisani, M.; Al-Hayani, A.; de Petrocellis, L.; Fezza, F.; Tognetto, M.; Petros, T.J.; Krey, J.F.; Chu, C.J.; et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. USA 2002, 99, 8400-8405.
171. Basavarajappa, B.S. Neuropharmacology of the endocannabinoid signaling system-Molecular mechanisms, biological actions and synaptic plasticity. Curr. Neuropharmacol. 2007, 5, 81-97.
172. Okamoto, Y.; Morishita, J.; Tsuboi, K.; Tonai, T.; Ueda, N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 2004, 279, 5298-5305.
173. Ueda, N.; Kurahashi, Y.; Yamamoto, S.; Tokunaga, T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 1995, 270, 23823-23827.
174. Simon, G.M.; Cravatt, B.F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 2008, 283, 9341-9349.
175. Liu, J.; Wang, L.; Harvey-White, J.; Huang, B.X.; Kim, H.Y.; Luquet, S.; Palmiter, R.D.; Krystal, G.; Rai, R.; Mahadevan, A.; et al. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 2008, 54, 1-7.
176. Liu, J.; Wang, L.; Harvey-White, J.; Osei-Hyiaman, D.; Razdan, R.; Gong, Q.; Chan, A.C.; Zhou, Z.; Huang, B.X.; Kim, H.Y.; et al. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. USA 2006, 103, 13345-13350.
177. Morishita, J.; Okamoto, Y.; Tsuboi, K.; Ueno, M.; Sakamoto, H.; Maekawa, N.; Ueda, N. Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain. J. Neurochem. 2005, 94, 753-762.
178. Nyilas, R.; Dudok, B.; Urban, G.M.; Mackie, K.; Watanabe, M.; Cravatt, B.F.; Freund, T.F.; Katona, I. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J. Neurosci. 2008, 28, 1058-1063.
179. Tsuboi, K.; Okamoto, Y.; Ikematsu, N.; Inoue, M.; Shimizu, Y.; Uyama, T.; Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and-independent pathways. Biochim. Biophys. Acta 2011, 1811, 565-577.
180. Leung, D.; Saghatelian, A.; Simon, G.M.; Cravatt, B.F. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry (Mosc.) 2006, 45, 4720-4726.
181. Simon, G.M.; Cravatt, B.F. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo. Mol. Biosyst. 2010, 6, 1411-1418.
182. Beltramo, M.; Piomelli, D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 2000, 11, 1231-1235.
183. Bisogno, T.; MacCarrone, M.; de Petrocellis, L.; Jarrahian, A.; Finazzi-Agro, A.; Hillard, C.; di Marzo, V. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem. 2001, 268, 1982-1989.
184. Hillard, C.J.; Edgemond, W.S.; Jarrahian, A.; Campbell, W.B. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 1997, 69, 631-638.
185. Beltramo, M.; Stella, N.; Calignano, A.; Lin, S.Y.; Makriyannis, A.; Piomelli, D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997, 277, 1094-1097.
186. Hillard, C.J.; Jarrahian, A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids 2000, 108, 123-134.
187. Maccarrone, M.; van der Stelt, M.; Rossi, A.; Veldink, G.A.; Vliegenthart, J.F.; Agro, A.F. Anandamide hydrolysis by human cells in culture and brain. J. Biol. Chem. 1998, 273, 32332-32339.
188. Giuffrida, A.; Beltramo, M.; Piomelli, D. Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology. J. Pharmacol. Exp. Ther. 2001, 298, 7-14.
189. Deutsch, D.G.; Glaser, S.T.; Howell, J.M.; Kunz, J.S.; Puffenbarger, R.A.; Hillard, C.J.; Abumrad, N. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J. Biol. Chem. 2001, 276, 6967-6973.
190. Glaser, S.T.; Abumrad, N.A.; Fatade, F.; Kaczocha, M.; Studholme, K.M.; Deutsch, D.G. Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. USA 2003, 100, 4269-4274.
191. Ahn, K.; Johnson, D.S.; Mileni, M.; Beidler, D.; Long, J.Z.; McKinney, M.K.; Weerapana, E.; Sadagopan, N.; Liimatta, M.; Smith, S.E.; et al. Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem. Biol. 2009, 16, 411-420.
192. Cravatt, B.F.; Demarest, K.; Patricelli, M.P.; Bracey, M.H.; Giang, D.K.; Martin, B.R.; Lichtman, A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 2001, 98, 9371-9376.
193. Kathuria, S.; Gaetani, S.; Fegley, D.; Valino, F.; Duranti, A.; Tontini, A.; Giustino, A.; Tattoli, M.; Palmery, M.; Cuomo, V.; et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 2003, 9, 76-81.
194. Berger, W.T.; Ralph, B.P.; Kaczocha, M.; Sun, J.; Balius, T.E.; Rizzo, R.C.; Haj-Dahmane, S.; Ojima, I.; Deutsch, D.G. Targeting fatty acid binding protein (FABP) anandamide transporters-A novel strategy for development of anti-inflammatory and anti-nociceptive drugs. PLoS ONE 2012, 7, e50968.
195. Kaczocha, M.; Glaser, S.T.; Deutsch, D.G. Identification of intracellular carriers for the endocannabinoid anandamide. Proc. Natl. Acad. Sci. USA 2009, 106, 6375-6380.
196. Kaczocha, M.; Rebecchi, M.J.; Ralph, B.P.; Teng, Y.H.; Berger, W.T.; Galbavy, W.; Elmes, M.W.; Glaser, S.T.; Wang, L.; Rizzo, R.C.; et al. Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. PLoS ONE 2014, 9, e94200.
197. Kaczocha, M.; Vivieca, S.; Sun, J.; Glaser, S.T.; Deutsch, D.G. Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J. Biol. Chem. 2012, 287, 3415-3424.
198. Burstein, S.H.; Rossetti, R.G.; Yagen, B.; Zurier, R.B. Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat. 2000, 61, 29-41.
199. Kozak, K.R.; Crews, B.C.; Morrow, J.D.; Wang, L.H.; Ma, Y.H.; Weinander, R.; Jakobsson, P.J.; Marnett, L.J. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem. 2002, 277, 44877-44885.
200. Ross, R.A.; Craib, S.J.; Stevenson, L.A.; Pertwee, R.G.; Henderson, A.; Toole, J.; Ellington, H.C. Pharmacological characterization of the anandamide cyclooxygenase metabolite: Prostaglandin E2 ethanolamide. J. Pharmacol. Exp. Ther. 2002, 301, 900-907.
201. Morozov, Y.M.; Ben-Ari, Y.; Freund, T.F. The spatial and temporal pattern of fatty acid amide hydrolase expression in rat hippocampus during postnatal development. Eur. J. Neurosci. 2004, 20, 459-466.
202. Aguado, T.; Palazuelos, J.; Monory, K.; Stella, N.; Cravatt, B.; Lutz, B.; Marsicano, G.; Kokaia, Z.; Guzmán, M.; Galve-Roperh, I. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J. Neurosci. 2006, 26, 1551-1561.
203. Sugiura, T.; Yoshinaga, N.; Kondo, S.; Waku, K.; Ishima, Y. Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. Biochem. Biophys. Res. Commun. 2000, 271, 654-658.
204. Basavarajappa, B.S. Critical Enzymes Involved in Endocannabinoid Metabolism. Protein Peptide Lett. 2007, 14, 237-246.
205. Gao, Y.; Vasilyev, D.V.; Goncalves, M.B.; Howell, F.V.; Hobbs, C.; Reisenberg, M.; Shen, R.; Zhang, M.Y.; Strassle, B.W.; Lu, P.; et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 2010, 30, 2017-2024.
206. Day, T.A.; Rakhshan, F.; Deutsch, D.G.; Barker, E.L. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Mol. Pharmacol. 2001, 59, 1369-1375.
207. Konrad, R.J.; Major, C.D.; Wolf, B.A. Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets: Sequential actions of diacylglycerol and monoacylglycerol lipases. Biochemistry (Mosc.) 1994, 33, 13284-13294.
208. Harkany, T.; Guzman, M.; Galve-Roperh, I.; Berghuis, P.; Devi, L.A.; Mackie, K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol. Sci. 2007, 28, 83-92.
209. Matias, I.; di Marzo, V. Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance. J. Endocrinol. Investig. 2006, 29, 15-26.
210. Piomelli, D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4, 873-884.
211. Van der Stelt, M.; Fox, S.H.; Hill, M.; Crossman, A.R.; Petrosino, S.; di Marzo, V.; Brotchie, J.M. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. FASEB J. 2005, 19, 1140-1142.
212. Berrendero, F.; Sepe, N.; Ramos, J.A.; di Marzo, V.; Fernandez-Ruiz, J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999, 33, 181-191.
213. Fernandez-Ruiz, J.; Berrendero, F.; Hernandez, M.L.; Ramos, J.A. The endogenous cannabinoid system and brain development. Trends Neurosci. 2000, 23, 14-20.
214. Paria, B.C.; Song, H.; Wang, X.; Schmid, P.C.; Krebsbach, R.J.; Schmid, H.H.; Bonner, T.I.; Zimmer, A.; Dey, S.K. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J. Biol. Chem. 2001, 276, 20523-20528.
215. Guzman, M. Cannabinoids: Potential anticancer agents. Nat. Rev. Cancer 2003, 3, 745-755.
216. Guzman, M.; Sanchez, C.; Galve-Roperh, I. Cannabinoids and cell fate. Pharmacol. Ther. 2002, 95, 175-184.
217. Berghuis, P.; Rajnicek, A.M.; Morozov, Y.M.; Ross, R.A.; Mulder, J.; Urban, G.M.; Monory, K.; Marsicano, G.; Matteoli, M.; Canty, A.; et al. Hardwiring the brain: Endocannabinoids shape neuronal connectivity. Science 2007, 316, 1212-1216.
218. Mulder, J.; Aguado, T.; Keimpema, E.; Barabas, K.; Ballester Rosado, C.J.; Nguyen, L.; Monory, K.; Marsicano, G.; di Marzo, V.; Hurd, Y.L.; et al. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc. Natl. Acad. Sci. USA 2008, 105, 8760-8765.
219. Berghuis, P.; Dobszay, M.B.; Wang, X.; Spano, S.; Ledda, F.; Sousa, K.M.; Schulte, G.; Ernfors, P.; Mackie, K.; Paratcha, G.; et al. Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc. Natl. Acad. Sci. USA 2005, 102, 19115-19120.
220. Berghuis, P.; Dobszay, M.B.; Ibanez, R.M.; Ernfors, P.; Harkany, T. Turning the heterogeneous into homogeneous: Studies on selectively isolated GABAergic interneuron subsets. Int. J. Dev. Neurosci. 2004, 22, 533-543.
221. Kim, D.; Thayer, S.A. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J. Neurosci. 2001, 21, RC146.
222. Galve-Roperh, I.; Aguado, T.; Rueda, D.; Velasco, G.; Guzman, M. Endocannabinoids: A new family of lipid mediators involved in the regulation of neural cell development. Curr. Pharm. Des. 2006, 12, 2319-2325.
223. Jaffe, A.B.; Hall, A. Rho GTPases: Biochemistry and biology. Annu. Rev. Cell Dev. Biol. 2005, 21, 247-269.
224. Jordan, J.D.; He, J.C.; Eungdamrong, N.J.; Gomes, I.; Ali, W.; Nguyen, T.; Bivona, T.G.; Philips, M.R.; Devi, L.A.; Iyengar, R. Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through Gαo/I-triggered proteasomal degradation of Rap1GAPII. J. Biol. Chem. 2005, 280, 11413-11421.
225. Williams, E.J.; Walsh, F.S.; Doherty, P. The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. J. Cell Biol. 2003, 160, 481-486.
226. Bisogno, T.; Howell, F.; Williams, G.; Minassi, A.; Cascio, M.G.; Ligresti, A.; Matias, I.; Schiano-Moriello, A.; Paul, P.; Williams, E.J.; et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 2003, 163, 463-468.
227. Howlett, A.C.; Johnson, M.R.; Melvin, L.S.; Milne, G.M. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Mol. Pharmacol. 1988, 33, 297-302.
228. Devane, W.A.; Dysarz, F.A.I.; Johnson, M.R.; Melvin, L.S.; Howlett, A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34, 605-613.
229. Jarai, Z.; Wagner, J.A.; Varga, K.; Lake, K.D.; Compton, D.R.; Martin, B.R.; Zimmer, A.M.; Bonner, T.I.; Buckley, N.E.; Mezey, E.; et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. USA 1999, 96, 14136-14141.
230. Wagner, J.A.; Varga, K.; Jarai, Z.; Kunos, G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 1999, 33, 429-434.
231. Di Marzo, V.; Breivogel, C.S.; Tao, Q.; Bridgen, D.T.; Razdan, R.K.; Zimmer, A.M.; Zimmer, A.; Martin, B.R. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: Evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 2000, 75, 2434-2444.
232. Breivogel, C.S.; Griffin, G.; di Marzo, V.; Martin, B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol. 2001, 60, 155-163.
233. Basavarajappa, B.S. Endocannabinoid signaling and alcohol addiction. In New Research on Alcoholism; Baye, D.R., Ed.; Nova Science Publishers, Inc.: New York, NY, USA, 2007; pp. 1-55.
234. Basavarajappa, B.S.; Yalamanchili, R.; Cooper, T.B.; Hungund, B.L. Endocannabinoid system. In Handbook of Neurochemistry and Molecular Neurobiology; Lajtha, A., Sylvester, E.V., Eds.; Springer: New York, NY, USA, 2008; pp. 343-384.
235. Herkenham, M.; Lynn, A.B.; Johnson, M.R.; Melvin, L.S.; de Cost, B.R.; Rice, K.C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci. 1991, 16, 8057-8066.
236. Munro, S.; Thomas, K.L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61-65.
237. Facci, L.; dal Toso, R.; Romanello, S.; Buriani, A.; Skaper, S.D.; Leon, A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 1995, 92, 3376-3380.
238. Onaivi, E.S.; Ishiguro, H.; Gong, J.P.; Patel, S.; Perchuk, A.; Meozzi, P.A.; Myers, L.; Mora, Z.; Tagliaferro, P.; Gardner, E.; et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N. Y. Acad. Sci. 2006, 1074, 514-536.
239. Van Sickle, M.D.; Duncan, M.; Kingsley, P.J.; Mouihate, A.; Urbani, P.; Mackie, K.; Stella, N.; Makriyannis, A.; Piomelli, D.; Davison, J.S.; et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310, 329-332.
240. Onaivi, E.S.; Ishiguro, H.; Gong, J.P.; Patel, S.; Meozzi, P.A.; Myers, L.; Perchuk, A.; Mora, Z.; Tagliaferro, P.A.; Gardner, E.; et al. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: From mice to human subjects. PLoS ONE 2008, 3, e1640.
241. Berrendero, F.; Garcia-Gil, L.; Hernandez, M.L.; Romero, J.; Cebeira, M.; de Miguel, R.; Ramos, J.A.; Fernández-Ruiz, J.J. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 1998, 125, 3179-3188.
242. Buckley, N.E.; Hansson, S.; Harta, G.; Mezey, E. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 1998, 82, 1131-1149.
243. Romero, J.; Garcia-Palomero, E.; Berrendero, F.; Garcia-Gil, L.; Hernandez, M.L.; Ramos, J.A.; Fernández-Ruiz, J.J. Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 1997, 26, 317-323.
244. Insel, T.R. The Development of Brain and Behavior. In Psychopharmacology: The Four Generation of Progress; Bloom, F.E., Kupfer, D.J. Eds.; Raven Press: New York, NY, USA, 1995; pp. 683-694.
245. Glass, M.; Dragunow, M.; Faull, R.L. Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77, 299-318.
246. Mailleux, P.; Vanderhaeghen, J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 1992, 48, 655-668.
247. Mukhopadhyay, S.; McIntosh, H.H.; Houston, D.B.; Howlett, A.C. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Mol. Pharmacol. 2000, 57, 162-170.
248. Childers, S.R.; Sexton, T.; Roy, M.B. Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 1994, 47, 711-715.
249. Pinto, J.C.; Potie, F.; Rice, K.C.; Boring, D.; Johnson, M.R.; Evans, D.M.; Wilken, G.H.; Cantrell, C.H.; Howlett, A.C. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. Mol. Pharmacol. 1994, 46, 516-522.
250. Howlett, A.C.; Mukhopadhyay, S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem. Phys. Lipids 2000, 108, 53-70.
251. Caulfield, M.P.; Brown, D.A. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 1992, 106, 231-232.
252. Mackie, K.; Hille, B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 1992, 89, 3825-3829.
253. Nogueron, M.I.; Porgilsson, B.; Schneider, W.E.; Stucky, C.L.; Hillard, C.J. Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. J. Neurochem. 2001, 79, 371-381.
254. Pan, X.; Ikeda, S.R.; Lewis, D.L. Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system. Mol. Pharmacol. 1996, 49, 707-714.
255. Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54, 161-202.
256. Mu, J.; Zhuang, S.Y.; Kirby, M.T.; Hampson, R.E.; Deadwyler, S.A. Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture. J. Pharmacol. Exp. Ther. 1999, 291, 893-902.
257. Freund, T.F.; Katona, I.; Piomelli, D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83, 1017-1066.
258. Wartmann, M.; Campbell, D.; Subramanian, A.; Burstein, S.H.; Davis, R.J. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett. 1995, 359, 133-136.
259. Bouaboula, M.; Poinot-Chazel, C.; Bourrie, B.; Canat, X.; Calandra, B.; Rinaldi-Carmona, M.; le Fur, G.; Casellas, P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 1995, 312, 637-641.
260. Derkinderen, P.; Toutant, M.; Burgaya, F.; le Bert, M.; Siciliano, J.C.; de Franciscis, V.; Gelman, M.; Girault, J.A. Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 1996, 273, 1719-1722.
261. Derkinderen, P.; Toutant, M.; Kadare, G.; Ledent, C.; Parmentier, M.; Girault, J.A. Dual role of Fyn in the regulation of FAK+6,7 by cannabinoids in hippocampus. J. Biol. Chem. 2001, 276, 38289-38296.
262. Ferna'ndez-Ruiz, J.J.; Bonnin, A.; Cebeira, M.; Ramos, J.A. Ontogenic and adults changes in the activity of hypothalamic and extrahypothalamic dopaminergic neurons after perinatal cannabinoid exposure. In Strategies for Studying Brain Disorders; Palomo, T., Archer, T., Eds.; Farrand Press: England, UK, 1994; pp. 357-390.
263. Ferna'ndez-Ruiz, J.J.; Rodriguez, F.; Navarro, M.; Ramos, J.A. Maternal cannabinoid exposure and brain development: Changes in the ontogeny of dopaminergic neurons. In Neurobiology and Neurophysiology of Cannabinoids: Biochemistry and Physiology of Substance Abuse; Bartke AaM, L.L., Ed.; CRC Press: Boca Raton, FL, USA, 1992; pp. 119-164.
264. Ferna'ndez-Ruiz, J.J.; Romero, J.; Garcı'a-Gil, L.; Garcı'a-Palomero, E.; Ramos, J.A. Dopaminergic neurons as neurochemical substrates of neurobehavioral effects of marihuana: Developmental and adult studies. In Dopamine Disease States; Beninger, R.J., Archer, T., Palomo, T., Eds.; CYM Press: Madrid, Spain, 1996; pp. 359-387.
265. Fernandez-Ruiz, J.J.; Berrendero, F.; Hernandez, M.L.; Romero, J.; Ramos, J.A. Role of endocannabinoids in brain development. Life Sci. 1999, 65, 725-736.
266. Dalterio, S.L. Perinatal or adult exposure to cannabinoids alters male reproductive functions in mice. Pharmacol. Biochem. Behav. 1980, 12, 143-153.
267. Navarro, M.; Rodriguez de Fonseca, F.; Hernandez, M.L.; Ramos, J.A.; Fernandez-Ruiz, J.J. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav. 1994, 47, 47-58.
268. Dalterio, S.L. Cannabinoid exposure: Effects on development. Neurobehav. Toxicol. Teratol. 1986, 8, 345-352.
269. Mokler, D.J.; Robinson, S.E.; Johnson, J.H.; Hong, J.S.; Rosecrans, J.A. Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat. Neurotoxicol. Teratol. 1987, 9, 321-327.
270. Vela, G.; Fuentes, J.A.; Bonnin, A.; Fernandez-Ruiz, J.; Ruiz-Gayo, M. Perinatal exposure to Δ9-tetrahydrocannabinol (Δ9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res. 1995, 680, 142-147.
271. Navarro, M.; de Miguel, R.; Rodriguez de Fonseca, F.; Ramos, J.A.; Fernandez-Ruiz, J.J. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav. Brain Res. 1996, 75, 91-98.
272. Vela, G.; Martin, S.; Garcia-Gil, L.; Crespo, J.A.; Ruiz-Gayo, M.; Fernandez-Ruiz, J.J.; García-Lecumberri, C.; Pélaprat, D.; Fuentes, J.A.; Ramos, J.A.; et al. Maternal exposure to Δ9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Res. 1998, 807, 101-109.
273. Dalterio, S.; Bartke, A. Perinatal exposure to cannabinoids alters male reproductive function in mice. Science 1979, 205, 1420-1422.
274. Shivachar, A.C.; Martin, B.R.; Ellis, E.F. Anandamide-and Δ9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboximide hydrochloride]. Biochem. Pharmacol. 1996, 51, 669-676.
275. Sanchez, C.; Galve-Roperh, I.; Rueda, D.; Guzman, M. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol. Pharmacol. 1998, 54, 834-843.
276. Sanchez, C.; Velasco, G.; Guzman, M. Δ9-tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells. Brain Res. 1997, 767, 64-71.
277. Bouaboula, M.; Bourrie, B.; Rinaldi-Carmona, M.; Shire, D.; le Fur, G.; Casellas, P. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J. Biol. Chem. 1995, 270, 13973-13980.
278. Hansen, H.H.; Krutz, B.; Sifringer, M.; Stefovska, V.; Bittigau, P.; Pragst, F.; Marsicano, G.; Lutz, B.; Ikonomidou, C. Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity. Ann. Neurol. 2008, 64, 42-52.
279. De Petrocellis, L.; Melck, D.; Palmisano, A.; Bisogno, T.; Laezza, C.; Bifulco, M.; di Marzo, V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl. Acad. Sci. USA 1998, 95, 8375-8380.
280. Galve-Roperh, I.; Sanchez, C.; Cortes, M.L.; Gomez del Pulgar, T.; Izquierdo, M.; Guzman, M. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 2000, 6, 313-319.
281. Stefanis, N.C.; Delespaul, P.; Henquet, C.; Bakoula, C.; Stefanis, C.N.; van Os, J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004, 99, 1333-1341.
282. Wu, C.S.; Jew, C.P.; Lu, H.C. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurol. 2011, 6, 459-480.
283. Twitchell, W.; Brown, S.; Mackie, K. Cannabinoids inhibit N-and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 1997, 78, 43-50.
284. Hampson, R.E.; Miller, F.; Palchik, G.; Deadwyler, S.A. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology 2011, 60, 944-952.
285. Basavarajappa, B.S.; Ninan, I.; Arancio, O. Acute Ethanol Suppresses Glutamatergic Neurotransmission through Endocannabinoids in Hippocampal Neurons. J. Neurochem. 2008, 107, 1001-1013.
286. Ikonomidou, C.; Bosch, F.; Miksa, M.; Bittigau, P.; Vockler, J.; Dikranian, K.; Tenkova, T.I.; Stefovska, V.; Turski, L.; Olney, J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283, 70-74.
287. Gerdeman, G.; Lovinger, D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 2001, 85, 468-471.
288. Huang, C.C.; Lo, S.W.; Hsu, K.S. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol. 2001, 532, 731-748.
289. Chevaleyre, V.; Castillo, P.E. Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 2004, 43, 871-881.
290. Sullivan, J.M. Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn. Mem. 2000, 7, 132-139.
291. Wilson, R.I.; Nicoll, R.A. Endocannabinoid Signaling in the Brain. Science 2002, 296, 678-682.
292. Mameli, M.; Zamudio, P.A.; Carta, M.; Valenzuela, C.F. Developmentally regulated actions of alcohol on hippocampal glutamatergic transmission. J. Neurosci. 2005, 25, 8027-8036.
293. Sadrian, B.; Lopez-Guzman, M.; Wilson, D.A.; Saito, M. Distinct neurobehavioral dysfunction based on the timing of developmental binge-like alcohol exposure. Neuroscience 2014, 280C, 204-219.
294. Vaglenova, J.; Pandiella, N.; Wijayawardhane, N.; Vaithianathan, T.; Birru, S.; Breese, C.; Suppiramaniam, V.; Randal, C. Aniracetam reversed learning and memory deficits following prenatal ethanol exposure by modulating functions of synaptic AMPA receptors. Neuropsychopharmacology 2008, 33, 1071-1083.
295. Margret, C.P.; Li, C.X.; Chappell, T.D.; Elberger, A.J.; Matta, S.G.; Waters, R.S. Prenatal alcohol exposure delays the development of the cortical barrel field in neonatal rats. Exp. Brain Res. 2006, 172, 1-13.
296. Medina, A.E.; Krahe, T.E.; Ramoa, A.S. Early alcohol exposure induces persistent alteration of cortical columnar organization and reduced orientation selectivity in the visual cortex. J. Neurophysiol. 2005, 93, 1317-1325.
297. Powrozek, T.A.; Zhou, F.C. Effects of prenatal alcohol exposure on the development of the vibrissal somatosensory cortical barrel network. Brain Res. Dev. Brain Res. 2005, 155, 135-146.
298. Zhou, F.C.; Sari, Y.; Powrozek, T.A. Fetal alcohol exposure reduces serotonin innervation and compromises development of the forebrain along the serotonergic pathway. Alcohol. Clin. Exp. Res. 2005, 29, 141-149.
299. Bohme, G.A.; Laville, M.; Ledent, C.; Parmentier, M.; Imperato, A. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 2000, 95, 5-7.
300. Reibaud, M.; Obinu, M.C.; Ledent, C.; Parmentier, M.; Bohme, G.A.; Imperato, A. Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur. J. Pharmacol. 1999, 379, R1-R2.
301. Fernandez-Ruiz, J.; Gomez, M.; Hernandez, M.; de Miguel, R.; Ramos, J.A. Cannabinoids and gene expression during brain development. Neurotox. Res. 2004, 6, 389-401.
302. Wang, X.; Dow-Edwards, D.; Anderson, V.; Minkoff, H.; Hurd, Y.L. Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. Pharm. J. 2006, 6, 255-264.
303. Schneider, M. Cannabis use in pregnancy and early life and its consequences: Animal models. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259, 383-393.
304. Campolongo, P.; Trezza, V.; Ratano, P.; Palmery, M.; Cuomo, V. Developmental consequences of perinatal cannabis exposure: Behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl.) 2011, 214, 5-15.
305. Kawash, G.F.; Yeung, D.L.; Berg, S.D. Effects of administration of cannabis resin during pregnancy on emotionality and learning in rats' offspring. Percept. Mot. Skills 1980, 50, 359-365.
306. Campolongo, P.; Trezza, V.; Cassano, T.; Gaetani, S.; Morgese, M.G.; Ubaldi, M.; Soverchia, L.; Antonelli, T.; Ferraro, L.; Massi, M.; et al. Perinatal exposure to Δ-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats. Addict. Biol. 2007, 12, 485-495.
307. Antonelli, T.; Tomasini, M.C.; Tattoli, M.; Cassano, T.; Tanganelli, S.; Finetti, S.; Mazzoni, E.; Trabace, L.; Steardo, L.; Cuomo, V.; et al. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb. Cortex. 2005, 15, 2013-2020.
308. Mereu, G.; Fa, M.; Ferraro, L.; Cagiano, R.; Antonelli, T.; Tattoli, M.; Ghiglieri, V.; Tanganelli, S.; Gessa, G.L.; Cuomo, V. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc. Natl. Acad. Sci. USA 2003, 100, 4915-4920.
309. O’Shea, M.; McGregor, I.S.; Mallet, P.E. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J. Psychopharmacol. 2006, 20, 611-621.
310. O’Shea, M.; Singh, M.E.; McGregor, I.S.; Mallet, P.E. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J. Psychopharmacol. 2004, 18, 502-508.
311. O’Shea, M.; Mallet, P.E. Impaired learning in adulthood following neonatal Δ9-THC exposure. Behav. Pharmacol. 2005, 16, 455-461.